Form 4 Tracker
Apellis Pharmaceuticals, Inc.
APLS

50 insider filings · Latest: May 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 12, 2025May 12 6:22 PMTownsend Adam J.
Proposed Sale
220,961$17.76$3.9M—

View →

Mar 17, 2025Mar 17 7:18 PMChopas James George
Proposed Sale
183$24.82$4.5K—

View →

Mar 5, 2025Mar 5 9:22 PMDAVID OSBORNE WATSON
Proposed Sale
5,569$25.10$139.8K—

View →

Feb 11, 2025Feb 11 8:13 PMDeLong Mark Jeffrey
Proposed Sale
363$28.54$10.4K—

View →

Jan 29, 2025Jan 29 8:42 PMTownsend Adam J.
Proposed Sale
695$29.52$20.5K—

View →

Jan 29, 2025Jan 29 8:26 PMSullivan Timothy Eugene
Proposed Sale
546$29.52$16.1K—

View →

Jan 29, 2025Jan 29 8:22 PMLewis Karen
Proposed Sale
364$29.52$10.7K—

View →

Jan 29, 2025Jan 29 8:18 PMNicholson Nur
Proposed Sale
825$29.52$24.4K—

View →

Jan 29, 2025Jan 29 8:17 PMDeLong Mark Jeffrey
Proposed Sale
365$29.52$10.8K—

View →

Jan 29, 2025Jan 29 8:16 PMWatson David O.
Proposed Sale
695$29.52$20.5K—

View →

Jan 29, 2025Jan 29 8:16 PMFrancois Cedric
Proposed Sale
2,824$29.52$83.4K—

View →

Jan 29, 2025Jan 29 8:12 PMEisele Jeffrey
Proposed Sale
278$29.52$8.2K—

View →

Jan 29, 2025Jan 29 8:11 PMDeschatelets Pascal
Proposed Sale
826$29.52$24.4K—

View →

Jan 22, 2025Jan 22 9:00 PMFrancois Cedric
Proposed Sale
13,551$30.43$412.3K—

View →

Jan 22, 2025Jan 22 8:56 PMWatson David O.
Proposed Sale
3,323$30.43$101.1K—

View →

Jan 22, 2025Jan 22 8:52 PMLewis Karen
Proposed Sale
1,751$30.43$53.3K—

View →

Jan 22, 2025Jan 22 8:51 PMSullivan Timothy Eugene
Proposed Sale
3,088$30.43$94.0K—

View →

Jan 22, 2025Jan 22 8:45 PMDeschatelets Pascal
Proposed Sale
3,948$30.43$120.1K—

View →

Jan 22, 2025Jan 22 8:45 PMTownsend Adam J.
Proposed Sale
3,323$30.43$101.1K—

View →

Jan 22, 2025Jan 22 8:44 PMDeLong Mark Jeffrey
Proposed Sale
1,396$30.43$42.5K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 14, 2026May 14 11:37 PMSinclair A. DunlopDirector
Disposition
102,826$59.860(D)

View →

May 14, 2026May 14 11:34 PMJames George ChopasVP/Chief Accounting Officer
Disposition
81,053$66.300(D)

View →

May 14, 2026May 14 11:34 PMMikael DolstenDirector
Disposition
24,135$20.960(D)

View →

May 14, 2026May 14 11:32 PMLeslie MeltzerChief Research and Development
Disposition
92,592$27.930(D)

View →

May 14, 2026May 14 11:31 PMPaul R. FonteyneDirector
Disposition
112,726$59.860(D)

View →

May 14, 2026May 14 11:30 PMTimothy Eugene SullivanChief Financial Officer
Disposition
677,390$66.300(D)

View →

May 14, 2026May 14 11:29 PMAlec MachielsDirector
Disposition
242,300$59.860(D)

View →

May 14, 2026May 14 11:27 PMPascal DeschateletsChief Scientific Officer
Disposition
588,996$66.300(D)

View →

May 14, 2026May 14 11:26 PMGerald ChanDirector
Disposition
242,300$59.860(D)

View →

May 14, 2026May 14 11:25 PMNur NicholsonChief Technical Officer
Disposition
357,594$66.300(D)

View →

May 14, 2026May 14 11:24 PMKeli WalbertDirector
Disposition
30,072$33.000(D)

View →

May 14, 2026May 14 11:23 PMMark Jeffrey DelongChief Business & Strat Officer
Disposition
235,736$66.300(D)

View →

May 14, 2026May 14 11:22 PMStephanie Monaghan O'BrienDirector
Disposition
242,300$59.860(D)

View →

May 14, 2026May 14 11:20 PMKelley BoucherChief People Officer
Disposition
146,138$28.170(D)

View →

May 14, 2026May 14 11:19 PMCraig A WheelerDirector
Disposition
42,879$25.120(D)

View →

May 14, 2026May 14 11:19 PMDavid O. WatsonGeneral Counsel
Disposition
302,965$66.300(D)

View →

May 14, 2026May 14 11:17 PMCedric FrancoisDirector, Chief Executive Officer
Disposition
1,697,706$66.300(D)

View →

May 14, 2026May 14 11:16 PMCaroline BaumalChief Medical Officer
Disposition
168,500$66.300(D)

View →

Feb 27, 2026Mar 3 9:06 PMMikael DolstenDirector
Grant/Award
24,135$20.9624,135(D)

View →

Feb 3, 2026Feb 5 9:14 PMCedric FrancoisDirector, Chief Executive Officer
Option Exercise
8,840$3.760(D)

View →